Detalhe da pesquisa
1.
Race-based differences in drug use prior to onset of opioid use disorder.
J Ethn Subst Abuse
; 22(1): 89-105, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554763
2.
Toward a National System of Expanded Testing of Existing Urine Specimens: The Drug Outbreak Testing Service (DOTS).
Subst Use Misuse
; 56(11): 1576-1585, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278971
3.
Notes from the Field: High Prevalence of Fentanyl Detected by the Maryland Emergency Department Drug Surveillance System - Baltimore, Maryland, 2019.
MMWR Morb Mortal Wkly Rep
; 69(23): 724-726, 2020 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525849
4.
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.
J Subst Use Addict Treat
; 145: 208946, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880915
5.
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
JAMA Netw Open
; 6(4): e237099, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043203
6.
"In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
J Subst Abuse Treat
; 138: 108721, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35067397
7.
Emergency Department Drug Surveillance (EDDS) hospital's urinalysis results compared with expanded re-testing by an independent laboratory, a pilot study.
Drug Alcohol Depend
; 230: 109195, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871979
8.
Using socially-sensed data to infer ZIP level characteristics for the spatiotemporal analysis of drug-related health problems in Maryland.
Health Place
; 63: 102345, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32543431
9.
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
BMJ Open
; 9(6): e026604, 2019 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31230007
10.
Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.
J Clin Invest
; 129(7): 2730-2744, 2019 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913037